Delivery Order SPE2DB25D3017-SPE2DB25FVKFX
Award Date 8/15/25
Potential Completion Date 8/18/25
Potential Value $5.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $52,764.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for MENQUADFI VIAL 0.5ML, with an ultimate completion date of November 19, 2025. This non-set-aside, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The place of performance is listed as Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,179.32 to AmerisourceBergen Drug Corp for MENQUADFI VIAL 0.5ML, a pharmaceutical product, with a completion date of August 20, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting AmerisourceBergen's capability to compete successfully in open federal procurement. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $2,110.59 delivery order to AmerisourceBergen Drug Corp for MENQUADFI VIAL 0.5ML, a pharmaceutical product, with a completion date of November 17, 2025. This non-set-aside, competitively awarded contract employs firm fixed price pricing and will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,110.59 to AmerisourceBergen Drug Corp for MENQUADFI Vial 0.5ML on November 4, 2025, with completion targeted for November 5, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside designation....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,392.08 to AmerisourceBergen Drug Corp for MENQUADFI VIAL 0.5ML on December 16, 2025, with an ultimate completion date of December 17, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,896.60 for MENQUADFI vial 0.5ML pharmaceutical products on June 2, 2025, with an ultimate completion date of June 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed in Conshohocken, Pennsylvania, where the contractor maintains its corporate headquarters. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $12,063.11 to AmerisourceBergen Drug Corp for MENQUADFI vial 0.5ML pharmaceutical products, with performance in Conshohocken, Pennsylvania and ultimate completion by September 22, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child award under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical supply vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $1,452.90 to AmerisourceBergen Drug Corp for MENQUADFI VIAL 0.5ML on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price contract was issued with no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,452.88 by the Defense Logistics Agency (DLA) for MENQUADFI VIAL 0.5ML, a pharmaceutical product. The contract is competitively awarded with no set-aside designation and operates under a firm fixed price structure, with an ultimate completion date of August 4, 2025. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $3,579.17 to AmerisourceBergen Drug Corp for Menquadfi Vial 0.5ML on December 4, 2025, with an ultimate completion date of December 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...